COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 1538: Articles 15371-15380  | Next

Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies
Misra, S., Kolappa, K., Prasad, M., Radhakrishnan, D., Thakur, K. T., Solomon, T., Michael, B. D., Winkler, A. S., Beghi, E., Guekht, A., Pardo, C. A. A., Wood, G. K., Chou, S. H.-Y., Fink, E. L., Schmutzhard, E., Kheradmand, A., Hoo, F. K., Kumar, A., Das, A., Srivastava, A. K., Agarwal, A., Dua, T., Prasad, K.
10.1101/2021.04.20.21255780 — Posted: 2021-04-23 Discussion: Onsite
COVID-19 vaccination acceptance among healthcare workers in Germany
Holzmann-Littig, C., Braunisch, M. C., Kranke, P., Popp, M., Seeber, C., Fichtner, F., Littig, B., Carbajo-Lozoya, J., Allwang, C., Frank, T., Meerpohl, J. J., Haller, B., Schmaderer, C.
10.1101/2021.04.20.21255794 — Posted: 2021-04-23
COV-ID: A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva
Warneford-Thomson, R., Shah, P. P., Lundgren, P., Lerner, J., Abella, B. S., Zaret, K. S., Schug, J., Jain, R., Thaiss, C. A., Bonasio, R.
10.1101/2021.04.23.21255523 — Posted: 2021-04-23
Comparing mental health trajectories of four different types of key workers with non-key workers: A 12-month follow-up observational study of 21,874 adults in England during the COVID-19 pandemic
Paul, E., Mak, H. W., Fancourt, D., Bu, F.
10.1101/2021.04.20.21255817 — Posted: 2021-04-23
Systematic review of the association between ABO blood type and COVID-19 incidence and mortality
Bai, Y., Yan, Z., Murray, E. J.
10.1101/2021.04.20.21255816 — Posted: 2021-04-23
Retrospective Assessment of Treatments of Hospitalized Covid-19 Patients
Ghooi, R., Lele, C., Motwani, M., Dixit, S., Venugopalan, P., Salvi, S., Bhat, S., Chaudhari, P., D'Costa, P., Jahagirdar, A., Mane, A., Padbidri, V., Pande, C., Shukla, U.
10.1101/2021.04.20.21255792 — Posted: 2021-04-23
A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report
Chitty, S. A., Mobbs, S., Rifkin, B. S., Stogner, S. W., Lewis, M. S., Betancourt, J., DellaVolpe, J., Abouzahr, F., Wilhelm, A. M., Szerlip, H. M., Gaeta, R. M., Rivera, I., Oliver, J. D., Olson, S. W., Debnath, S., Barnett, S. P., Parikh, A., Walter, R. J., Nguyen, M. T., Sullivan, B., Alcover, K. C., Stewart, I. J., Pratt, K. P., Sharma, K., Chung, K. K., PURIFY INVESTIGATORS
10.1101/2021.04.20.21255810 — Posted: 2021-04-23
Inactivation of SARS-CoV-2 by β-propiolactone Causes Aggregation of Viral Particles and Loss of Antigenic Potential
Gupta, D., Parthasarathy, H., Sah, V., Tandel, D., Vedagiri, D., Reddy, S., Harshan, K. H.
10.1101/2021.04.22.441045 — Posted: 2021-04-23
The Great Deceiver: miR-2392's Hidden Role in Driving SARS-CoV-2 Infection
McDonald, J. T., Enguita, F. J., Taylor, D., Bowen, R. A., Griffin, R. J., Priebe, W., Emmett, M. R., McGrath, M., Sajadi, M., Harris, A. D., Clement, J., Dybas, J. M., Aykin-Burns, N., Guarnieri, J. W., Singh, L. N., Grabham, P., Baylin, S., Yousey, A., Pearson, A. N., Corry, P. M., Saravia-Butler, A., Aunins, T. R., Nagpal, P., Meydan, C., Foox, J., Mozsary, C., Cerqueira, B., Zaksas, V., Singh, U., Wurtele, E. S., Costes, S. V., Galeano, D., Paccanaro, A., Meinig, S. L., Hagan, R. S., Bowman, N. M., UNC COVID-19 Pathobiology Consortium, , Wolfgang, M. C., Altinok, S., Sapoval, N., Treangen, T. J., Frieman, M., Vanderburg, C., Schisler, J. C., Mason, C., Chatterjee, A., Meller, R., Beheshti, A.
10.1101/2021.04.23.441024 — Posted: 2021-04-23
Computational investigation reveals that the mutant strains of SARS-CoV2 are highly infectious than wildtype
Kumar, R., Kumar, R., Goel, H., Tanwar, P.
10.1101/2021.04.23.441125 — Posted: 2021-04-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).